Sichenzia Ross Ference LLP Represents Sunshine Biopharma, Inc. in $8 Million Private Placement

Press Release – New York, NY – March 15, 2022 – Sichenzia Ross Ference LLP today announced that it represented Sunshine Biopharma, Inc.,  a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs (NASDAQ: SBFM), in a $8.0 million private placement.  The offering included 2,301,353 shares of common stock together with common warrants to purchase up to 2,301,353 shares of common stock, and 1,302,251 pre-funded warrants, together with common warrants to purchase up to 1,302,251 shares of common stock.  Each share of common stock and accompanying common warrant were sold together at a combined offering price of $2.22, and each pre-funded warrant and accompanying common warrant were sold together at a combined offering price of $2.219.  The common warrants have an exercise price of $2.22 per share.  The gross proceeds to the Company from the offering were approximately $8.0 million.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Jeff Cahlon and David Manno and associate Michael Blane.

• Author
• Recent Posts

Sichenzia Ross Ference Carmel LLP

SRFC is a full-service law firm with nationally recognized corporate, securities, and litigation practices that provides experienced representation in all matters involving the securities industry. In addition to handling routine to complex commercial matters, SRFC’s renowned litigation and regulatory department specializes in defending broker-dealers, registered persons, public and private corporations, and individuals in investigations and enforcement proceedings before the SEC, FINRA, and other regulatory bodies, as well as litigations and arbitrations across all forums in the securities industry, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations.

Latest posts by Sichenzia Ross Ference Carmel LLP (see all)

• Sichenzia Ross Ference Carmel LLP Represents Safe & Green Holdings Corp. in a $8.0 Million Private Placement - April 15, 2025
• Sichenzia Ross Ference Carmel LLP Represents FatPipe, Inc. in Closing of $4 Million Initial Public Offering - April 10, 2025
• Sichenzia Ross Ference Carmel Names Matilde Tysz as Chief Strategy Officer - April 9, 2025